The use of biologics in the treatment of rheumatoid arthritis (RA)--the good news and the bad news.
McQueen
F M
FM
Department of Molecular Medicine, Auckland School of Medicine, New Zealand.
D000911:Antibodies, Monoclonal / Q000502:physiology / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000628:therapy*; D002986:Clinical Trials as Topic; D016207:Cytokines / Q000502:physiology / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D008954:Models, Biological; D018121:Receptors, Cytokine / Q000037:antagonists & inhibitors / Q000502:physiology
D000911:Antibodies, Monoclonal; D016207:Cytokines; D018121:Receptors, Cytokine